Anchor Investment Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $445 | Hold |
25
| – | – | ﹤0.01% | 1017 |
|
|
2025
Q1 | $446 | Hold |
25
| – | – | ﹤0.01% | 1011 |
|
|
2024
Q4 | $745 | Hold |
25
| – | – | ﹤0.01% | 984 |
|
|
2024
Q3 | $391 | Hold |
25
| – | – | ﹤0.01% | 1023 |
|
|
2024
Q2 | $428 | Hold |
25
| – | – | ﹤0.01% | 973 |
|
|
2024
Q1 | $391 | Hold |
25
| – | – | ﹤0.01% | 1011 |
|
|
2023
Q4 | $373 | Hold |
25
| – | – | ﹤0.01% | 940 |
|
|
2023
Q3 | $404 | Hold |
25
| – | – | ﹤0.01% | 956 |
|
|
2023
Q2 | $1.04K | Hold |
25
| – | – | ﹤0.01% | 920 |
|
|
2023
Q1 | $1.5K | Hold |
25
| – | – | ﹤0.01% | 925 |
|
|
2022
Q4 | $1.83K | Hold |
25
| – | – | ﹤0.01% | 878 |
|
|
2022
Q3 | $1.9K | Hold |
25
| – | – | ﹤0.01% | 889 |
|
|
2022
Q2 | $1.74K | Hold |
25
| – | – | ﹤0.01% | 901 |
|
|
2022
Q1 | $2.07K | Hold |
25
| – | – | ﹤0.01% | 909 |
|
|
2021
Q4 | $1.88K | Buy |
+25
| New | +$1.88K | ﹤0.01% | 941 |
|